Cargando…

Performance of Deauville Criteria in ([18F])FDG-PET/CT Diagnostics of Giant Cell Arteritis

In this retrospective study, PET/CT data from 59 patients with suspected giant cell arteritis (GCA) were reviewed using the Deauville criteria to determine an optimal cut-off between PET positivity and negativity. Seventeen standardised vascular regions were analysed per patient by three investigato...

Descripción completa

Detalles Bibliográficos
Autores principales: Siefert, Jeffrey, Kaufmann, Jonas, Thiele, Felix, Walter-Rittel, Thula, Rogasch, Julian, Biesen, Robert, Burmester, Gerd R., Amthauer, Holger, Schneider, Udo, Furth, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818714/
https://www.ncbi.nlm.nih.gov/pubmed/36611449
http://dx.doi.org/10.3390/diagnostics13010157
_version_ 1784865053654122496
author Siefert, Jeffrey
Kaufmann, Jonas
Thiele, Felix
Walter-Rittel, Thula
Rogasch, Julian
Biesen, Robert
Burmester, Gerd R.
Amthauer, Holger
Schneider, Udo
Furth, Christian
author_facet Siefert, Jeffrey
Kaufmann, Jonas
Thiele, Felix
Walter-Rittel, Thula
Rogasch, Julian
Biesen, Robert
Burmester, Gerd R.
Amthauer, Holger
Schneider, Udo
Furth, Christian
author_sort Siefert, Jeffrey
collection PubMed
description In this retrospective study, PET/CT data from 59 patients with suspected giant cell arteritis (GCA) were reviewed using the Deauville criteria to determine an optimal cut-off between PET positivity and negativity. Seventeen standardised vascular regions were analysed per patient by three investigators blinded to clinical information. Statistical analysis included ROC curves with areas under the curve (AUC), Cohen’s and Fleiss’ kappa (κ) to calculate sensitivity, specificity, accuracy, and agreement. According to final clinician’s diagnosis and the revised 2017 ACR criteria GCA was confirmed in 29 of 59 (49.2 %) patients. With a diagnostic cut-off ≥ 4 (highest tracer uptake of a vessel wall exceeds liver uptake) for PET positivity, all investigators achieved high accuracy (range, 89.8–93.2%) and AUC (range, 0.94–0.97). Sensitivity and specificity ranged from 89.7–96.6% and 83.3–96.7%, respectively. Agreement between the three investigators suggested ‘almost perfect agreement’ (Fleiss’ κ = 0.84) A Deauville score of ≥4 as threshold for PET positivity yielded excellent results with high accuracy and almost perfect inter-rater agreement, suggesting a standardized, reproducible, and reliable score in diagnosing GCA. However, the small sample size and reference standard could lead to biases. Therefore, verification in a multicentre study with a larger patient cohort and prospective setting is needed.
format Online
Article
Text
id pubmed-9818714
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98187142023-01-07 Performance of Deauville Criteria in ([18F])FDG-PET/CT Diagnostics of Giant Cell Arteritis Siefert, Jeffrey Kaufmann, Jonas Thiele, Felix Walter-Rittel, Thula Rogasch, Julian Biesen, Robert Burmester, Gerd R. Amthauer, Holger Schneider, Udo Furth, Christian Diagnostics (Basel) Article In this retrospective study, PET/CT data from 59 patients with suspected giant cell arteritis (GCA) were reviewed using the Deauville criteria to determine an optimal cut-off between PET positivity and negativity. Seventeen standardised vascular regions were analysed per patient by three investigators blinded to clinical information. Statistical analysis included ROC curves with areas under the curve (AUC), Cohen’s and Fleiss’ kappa (κ) to calculate sensitivity, specificity, accuracy, and agreement. According to final clinician’s diagnosis and the revised 2017 ACR criteria GCA was confirmed in 29 of 59 (49.2 %) patients. With a diagnostic cut-off ≥ 4 (highest tracer uptake of a vessel wall exceeds liver uptake) for PET positivity, all investigators achieved high accuracy (range, 89.8–93.2%) and AUC (range, 0.94–0.97). Sensitivity and specificity ranged from 89.7–96.6% and 83.3–96.7%, respectively. Agreement between the three investigators suggested ‘almost perfect agreement’ (Fleiss’ κ = 0.84) A Deauville score of ≥4 as threshold for PET positivity yielded excellent results with high accuracy and almost perfect inter-rater agreement, suggesting a standardized, reproducible, and reliable score in diagnosing GCA. However, the small sample size and reference standard could lead to biases. Therefore, verification in a multicentre study with a larger patient cohort and prospective setting is needed. MDPI 2023-01-03 /pmc/articles/PMC9818714/ /pubmed/36611449 http://dx.doi.org/10.3390/diagnostics13010157 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Siefert, Jeffrey
Kaufmann, Jonas
Thiele, Felix
Walter-Rittel, Thula
Rogasch, Julian
Biesen, Robert
Burmester, Gerd R.
Amthauer, Holger
Schneider, Udo
Furth, Christian
Performance of Deauville Criteria in ([18F])FDG-PET/CT Diagnostics of Giant Cell Arteritis
title Performance of Deauville Criteria in ([18F])FDG-PET/CT Diagnostics of Giant Cell Arteritis
title_full Performance of Deauville Criteria in ([18F])FDG-PET/CT Diagnostics of Giant Cell Arteritis
title_fullStr Performance of Deauville Criteria in ([18F])FDG-PET/CT Diagnostics of Giant Cell Arteritis
title_full_unstemmed Performance of Deauville Criteria in ([18F])FDG-PET/CT Diagnostics of Giant Cell Arteritis
title_short Performance of Deauville Criteria in ([18F])FDG-PET/CT Diagnostics of Giant Cell Arteritis
title_sort performance of deauville criteria in ([18f])fdg-pet/ct diagnostics of giant cell arteritis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818714/
https://www.ncbi.nlm.nih.gov/pubmed/36611449
http://dx.doi.org/10.3390/diagnostics13010157
work_keys_str_mv AT siefertjeffrey performanceofdeauvillecriteriain18ffdgpetctdiagnosticsofgiantcellarteritis
AT kaufmannjonas performanceofdeauvillecriteriain18ffdgpetctdiagnosticsofgiantcellarteritis
AT thielefelix performanceofdeauvillecriteriain18ffdgpetctdiagnosticsofgiantcellarteritis
AT walterrittelthula performanceofdeauvillecriteriain18ffdgpetctdiagnosticsofgiantcellarteritis
AT rogaschjulian performanceofdeauvillecriteriain18ffdgpetctdiagnosticsofgiantcellarteritis
AT biesenrobert performanceofdeauvillecriteriain18ffdgpetctdiagnosticsofgiantcellarteritis
AT burmestergerdr performanceofdeauvillecriteriain18ffdgpetctdiagnosticsofgiantcellarteritis
AT amthauerholger performanceofdeauvillecriteriain18ffdgpetctdiagnosticsofgiantcellarteritis
AT schneiderudo performanceofdeauvillecriteriain18ffdgpetctdiagnosticsofgiantcellarteritis
AT furthchristian performanceofdeauvillecriteriain18ffdgpetctdiagnosticsofgiantcellarteritis